Also trades as: PFIZER.BO (BSE) · $vol 0M
PFIZER.NS NSE
Pfizer Limited
1W: -4.6%
1M: -17.3%
3M: -14.2%
YTD: -22.2%
1Y: -32.3%
3Y: +4.0%
5Y: -32.7%
₹3,857.00 ($40.09)
-18.30 (-0.47%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$11.4B
+73.3% ▲
5Y CAGR: +21.8%
Capital Expenditures
$252M
+10.4% ▲
5Y CAGR: +7.3%
Free Cash Flow
$11.2B
+77.1% ▲
5Y CAGR: +22.2%
Dividends Paid
$7.5B
-369.0% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$26.0B
+578.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $7.7B | $8.2B | $5.5B | $7.7B | $7.2B |
| Depreciation & Amort. | $1.1B | $1.1B | $623M | $608M | $577M |
| Stock-Based Comp. | $118M | $127M | $144M | $137M | $0 |
| Change in Working Capital | $434M | -$345M | -$2.5B | $568M | $402M |
| Other Non-Cash Items | -$2.8B | -$5.5B | -$1.3B | -$2.4B | $3.2B |
| Operating Cash Flow | $6.7B | $3.6B | $2.6B | $6.6B | $11.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$153M | -$650M | -$189M | -$282M | -$252M |
| Acquisitions (Net) | $21M | $1.8B | $529M | $1.5B | $12M |
| Investment Purchases | -$6.1B | -$2.3B | -$1.1B | -$3.5B | -$7.1B |
| Investment Sales | -$21M | $2.3B | $0 | $0 | $0 |
| Other Investing | $528M | -$1.5B | $39M | $1.6B | $0 |
| Investing Cash Flow | -$5.8B | -$360M | -$713M | -$713M | -$7.4B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$99M | -$352M | -$373M | -$373M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1.6B | -$3.0B | -$1.8B | -$1.6B | -$7.5B |
| Other Financing | -$109M | -$134M | $154M | -$78M | -$457M |
| Financing Cash Flow | -$1.8B | -$3.5B | -$2.1B | -$2.1B | -$8.0B |
| Net Change in Cash | -$884M | -$262M | $754M | $3.8B | $26.0B |
| Cash End of Period | $628M | $366M | $1.1B | $5.0B | $31.1B |
| Free Cash Flow | $6.5B | $2.9B | $2.4B | $6.3B | $11.2B |